The Insulin-like growth factor 2 (IGF-2) has been recently proven to alleviate depressive-like
behaviors in both rats and mice models. However, its potential role as a peripheral …

Insulin-like growth factor 2 (IGF-2) and IGF binding protein 7 (IGFBP-7) have been related to
schizophrenia (SZ) due to their implication in neurodevelopment. The purpose of this study …

Objective We aimed to investigate if there is a significant difference in peripheral insulin‐like
growth factor 1 (IGF‐1) levels between schizophrenia patients and healthy controls and to …

Abstract Treatment-resistant schizophrenia (TRS) is associated with great disability,
functional impairment, and substantial socioeconomic costs. While clozapine is indicated in …

Background Numerous studies have implicated abnormal insulin-like growth factor 1 (IGF-1)
in the pathophysiology of schizophrenia, but findings have been inconsistent. Methods We …

Objective: The effects of metabolic changes on neural structures in the later stages of
schizophrenia remain unknown. Alterations in glucose and lipid metabolism could impact …

Objective: The effects of metabolic changes on neural structures in the later stages of
schizophrenia remain unknown. Alterations in glucose and lipid metabolism could impact …

One of psychiatry's significant challenges lies in differentiating certain mental illnesses,
given the overlapping characteristics exhibited by many of them. The identification of a …

Objective: Alterations in blood flow and inflammation may be associated with the treatment
response of psychotic disorders. However, changes in blood viscosity in patients with …

Objective: The effects of metabolic changes on neural structures in the later stages of
schizophrenia remain unknown. Alterations in glucose and lipid metabolism could impact …